Research on New Strategies for Tumor Therapy Based on Nanostructured Materials

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: 20 June 2024 | Viewed by 2297

Special Issue Editor

E-Mail Website
Guest Editor
Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia
Interests: cancer therapy; tumor models; nanomaterials; combination therapy

Special Issue Information

Dear Colleagues,

Despite being one of the most investigated diseases, cancer is still causing excessive burden that reaches much further than the affected person. Nanomaterial-based therapies, in addition to biological-based approaches, are one of the fastest developing new modalities to fight cancer. These efforts have already resulted in hundreds of new modalities based on unique and sometimes unexpected properties of nanomaterials. Being inorganic, organic, or biomaterial-based; "soft" or "hard"; with a core or hollow; and serving as either carriers of drugs, radioisotopes, or immune system triggers, these materials are proven to be capable of fighting cancers. However, this battle is far from over. Rather, it is just beginning. Relying on an endless pool of unique properties of nanomaterials, new modalities appear every day. In this Special Issue, we would like to shed light on the recent status and offer a glimpse of the future perspective of fighting cancer using the unique properties of nanomaterials.

I look forward to receiving your contributions.

Dr. Željko Prijović
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • cancer
  • tumor
  • nanomaterial-based therapies
  • nanomaterials
  • nanostructured

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


28 pages, 5511 KiB  
Evaluation of Advanced Nanomaterials for Cancer Diagnosis and Treatment
by Nkanyiso L. Ndlovu, Wendy B. Mdlalose, Bulelwa Ntsendwana and Thomas Moyo
Pharmaceutics 2024, 16(4), 473; - 28 Mar 2024
Cited by 1 | Viewed by 1945
Cancer is a persistent global disease and a threat to the human species, with numerous cases reported every year. Over recent decades, a steady but slowly increasing mortality rate has been observed. While many attempts have been made using conventional methods alone as [...] Read more.
Cancer is a persistent global disease and a threat to the human species, with numerous cases reported every year. Over recent decades, a steady but slowly increasing mortality rate has been observed. While many attempts have been made using conventional methods alone as a theragnostic strategy, they have yielded very little success. Most of the shortcomings of such conventional methods can be attributed to the high demands of industrial growth and ever-increasing environmental pollution. This requires some high-tech biomedical interventions and other solutions. Thus, researchers have been compelled to explore alternative methods. This has brought much attention to nanotechnology applications, specifically magnetic nanomaterials, as the sole or conjugated theragnostic methods. The exponential growth of nanomaterials with overlapping applications in various fields is due to their potential properties, which depend on the type of synthesis route used. Either top-down or bottom-up strategies synthesize various types of NPs. The top-down only branches out to one method, i.e., physical, and the bottom-up has two methods, chemical and biological syntheses. This review highlights some synthesis techniques, the types of nanoparticle properties each technique produces, and their potential use in the biomedical field, more specifically for cancer. Despite the evident drawbacks, the success achieved in furthering nanoparticle applications to more complex cancer stages and locations is unmatched. Full article
Show Figures

Figure 1

Back to TopTop